Lymphoma Therapy; Rituximab with chemotherapy shows promise for splenic MZL treatment
Lymphoma Therapy; Rituximab with chemotherapy shows promise for splenic MZL treatment
About this item
Full title
Publisher
Atlanta: NewsRx
Journal title
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
In their study, the collaborators "employed an immunochemotherapy regimen with rituximab/cyclophosphamide/vincristine in three patients with splenic MZL who had only a partial response following CHOP (cyclophosphamide/doxorubicin/vincristine/prednisone) or CHOP- like therapy."
Alternative Titles
Full title
Lymphoma Therapy; Rituximab with chemotherapy shows promise for splenic MZL treatment
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_206427260
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_206427260
Other Identifiers
ISSN
1531-6440
E-ISSN
1532-4575